Connection

ANTHONY ZOGHBI to Humans

This is a "connection" page, showing publications ANTHONY ZOGHBI has written about Humans.
Connection Strength

0.173
  1. Genome-wide prediction of dominant and recessive neurodevelopmental disorder-associated genes. Am J Hum Genet. 2025 Mar 06; 112(3):693-708.
    View in: PubMed
    Score: 0.026
  2. The neurobiology of duration of untreated psychosis: a comprehensive review. Mol Psychiatry. 2023 01; 28(1):168-190.
    View in: PubMed
    Score: 0.022
  3. High-impact rare genetic variants in severe schizophrenia. Proc Natl Acad Sci U S A. 2021 12 21; 118(51).
    View in: PubMed
    Score: 0.021
  4. Schizotypal personality disorder in individuals with the Attenuated Psychosis Syndrome: Frequent co-occurrence without an increased risk for conversion to threshold psychosis. J Psychiatr Res. 2019 07; 114:88-92.
    View in: PubMed
    Score: 0.017
  5. Alive but not well: the limited validity but continued utility of the concept of schizophrenia. Psychol Med. 2018 01; 48(2):245-246.
    View in: PubMed
    Score: 0.016
  6. Cognitive function and suicide risk in Han Chinese inpatients with schizophrenia. Psychiatry Res. 2014 Dec 15; 220(1-2):188-92.
    View in: PubMed
    Score: 0.013
  7. Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases. Nat Commun. 2025 Feb 19; 16(1):1779.
    View in: PubMed
    Score: 0.007
  8. Pharmacogenomic insights in psychiatric care: uncovering novel actionability, allele-specific CYP2D6 copy number variation, and phenoconversion in 15,000 patients. Mol Psychiatry. 2024 Nov; 29(11):3495-3502.
    View in: PubMed
    Score: 0.006
  9. An evolutionary perspective on complex neuropsychiatric disease. Neuron. 2024 Jan 03; 112(1):7-24.
    View in: PubMed
    Score: 0.006
  10. Latin American Trans-ancestry INitiative for OCD genomics (LATINO): Study protocol. Am J Med Genet B Neuropsychiatr Genet. 2024 Jun; 195(4):e32962.
    View in: PubMed
    Score: 0.006
  11. Human genetics uncovers MAP3K15 as an obesity-independent therapeutic target for diabetes. Sci Adv. 2022 11 18; 8(46):eadd5430.
    View in: PubMed
    Score: 0.006
  12. The benefit of diagnostic whole genome sequencing in schizophrenia and other psychotic disorders. Mol Psychiatry. 2022 03; 27(3):1435-1447.
    View in: PubMed
    Score: 0.005
  13. Exome sequencing in obsessive-compulsive disorder reveals a burden of rare damaging coding variants. Nat Neurosci. 2021 08; 24(8):1071-1076.
    View in: PubMed
    Score: 0.005
  14. A Transcriptome-Based Drug Discovery Paradigm for Neurodevelopmental Disorders. Ann Neurol. 2021 02; 89(2):199-211.
    View in: PubMed
    Score: 0.005
  15. The past and future of novel, non-dopamine-2 receptor therapeutics for schizophrenia: A critical and comprehensive review. J Psychiatr Res. 2019 01; 108:57-83.
    View in: PubMed
    Score: 0.004
  16. Increased serum brain-derived neurotrophic factor levels during opiate withdrawal. Neurosci Lett. 2014 Jun 13; 571:61-5.
    View in: PubMed
    Score: 0.003
  17. Prevalence, demographic and clinical correlates of suicide attempts in Chinese medicated chronic inpatients with schizophrenia. J Psychiatr Res. 2013 Oct; 47(10):1370-5.
    View in: PubMed
    Score: 0.003
  18. The amyotrophic lateral sclerosis 8 protein VAPB is cleaved, secreted, and acts as a ligand for Eph receptors. Cell. 2008 Jun 13; 133(6):963-77.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.